Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis (IPF)

Explore clinical trials studying Idiopathic Pulmonary Fibrosis (IPF). Study availability and eligibility vary by location and protocol.

61 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis (IPF) trial results

Recruiting

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

NCT07652658

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Loma Linda, California, United States
View all 195 locations
View Trial Details
Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

NCT06968845

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • UAB Lung Health Center Birmingham, Alabama, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Paradigm Clinical Research Centers, LLC San Diego, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 36 locations
View Trial Details
Recruiting

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

NCT07284602

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), +6 more
Locations
  • Palmtree Clinical Research Inc. Palm Spring, California, United States
  • Paradigm Clinical Research Centers LLC Redding, California, United States
  • Infinity Medical Research North Dartmouth, Massachusetts, United States
  • Clinical Research Associates of Central PA DuBois, Pennsylvania, United States
View Trial Details
Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

NCT06951217

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • Renstar Medical Research Ocala, Florida, United States
View all 72 locations
View Trial Details
Recruiting

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

NCT07194382

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations
  • Nepean Lung and Sleep Kingswood, New South Wales, Australia
  • Dynamic Drug Advancement Ajax, Ontario, Canada
  • CIC Mauricie Trois-Rivières, Quebec, Canada
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
View all 24 locations
View Trial Details

Related conditions